Latest news with #Schweiz
Associated Press
25-05-2025
- Business
- Associated Press
Happypot Launches as Switzerland's First Fully Localized Platform for Online Money Pots and Crowdfunding
'We'd like to thank you for the ease of use and reliability of your online Pot system. We've received your transfer! A first experience that convinced us!'— Anouk T ZüRICH, ZüRICH, SWITZERLAND, May 25, 2025 / / -- ZURICH, Switzerland, A new Swiss platform is transforming how individuals and communities across Switzerland come together to fund gifts, causes, and collective events. Happy pot, a Zurich based fintech startup, has officially launched as the country's first online money pot and local crowdfunding solution fully built around Swiss cultural, linguistic, and financial norms. Unlike international platforms that often overlook the nuances of local users, has been developed specifically for the Swiss market. From seamless integration with preferred local payment systems like Twint and direct IBAN transfers to a multilingual interface supporting French, German, Italian, and English, the platform reflects how people in Switzerland actually give and celebrate together. Since its launch, has experienced over 25% growth, signaling strong demand for a platform that reflects the values of Swiss users. Unlike global crowdfunding tools to be use often miss local nuances, was purpose built for the Swiss public from integration with preferred local payment systems like Twint and direct IBAN transfers to a multilingual interface in French, German, Italian, and English. By combining the convenience of digital gifting with the precision of Swiss design, is quickly becoming the go to platform for those looking to invest in a Swiss fintech solution that prioritizes trust, transparency, and community first innovation. As Switzerland continues to see increasing demand for trusted digital solutions in the financial and social space, early traction has attracted attention from local investors and institutions. The platform's scalable design and compliance with GDPR and Swiss data privacy laws have made it a promising contender in the European fintech and community giving landscape. The company is currently expanding its partnerships with schools, non profit organizations, and employers. It also plans to explore strategic growth into culturally similar regions, including Austria, Luxembourg, and Belgium. Future updates will include AI powered personalization and deeper integrations with Swiss civic and financial ecosystems. About Headquartered in Zurich, is Switzerland's leading online platform for creating money pots and managing collective contributions. Built entirely in Switzerland, the platform combines trust, elegance, and emotional simplicity to redefine crowdfunding Switzerland for everyday people, institutions, and organizations. For Switzerland's fintech scene, the emergence of signals a shift toward more culturally conscious innovation where digital tools are not only functional but thoughtfully aligned with national values and day-to-day traditions. +41 78 480 61 69 email us here Visit us on social media: LinkedIn Instagram Facebook YouTube Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
South China Morning Post
14-05-2025
- Politics
- South China Morning Post
Germany arrests 3 Ukrainians over Russian sabotage plot
German prosecutors said on Wednesday they had arrested three Ukrainians accused of plotting sabotage attacks on goods transports for Russia , amid soaring tensions between Moscow and Berlin. Advertisement The suspects, detained in Germany and Switzerland, had told individuals 'believed to be acting on behalf of Russian state authorities' that they were ready 'to commit arson and explosive attacks on goods transport in Germany', federal prosecutors said. The accused allegedly aimed to send packages from Germany containing explosive devices to recipients in Ukraine , which would go off as they were being transported, they said. Germany has been on high alert for sabotage plots directed from Moscow since Russia's 2022 full-scale invasion of Ukraine led to a rapid deterioration in ties. In a speech to parliament on Wednesday, new Chancellor Friedrich Merz accused Russia of targeting Germany and other European countries with acts ranging from cyberattacks, espionage and sabotage to disinformation, poison attacks and murders. German Chancellor Friedrich Merz delivers a government statement during a session of the German parliament in Berlin on Wednesday. Photo: EPA-EFE Such acts were 'overwhelmingly the work of the Russian government and its helpers', he said, accusing Moscow of 'attempts at division and destabilisation'.
Yahoo
06-05-2025
- Business
- Yahoo
Swiss biotech sector's R&D investment grew in 2024 despite global trends
Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles. While many countries have seen a decline in investment in recent years, according to the Swiss Biotech Report 2025, investment into R&D in Switzerland reached SFr2.6bn ($3.16bn) in 2024, with private company investment accounting for SFr1.4bn of that. Apart from R&D investment, companies in Switzerland raised SFr2.5bn in funds in 2024, a 22% increase on 2023. Revenues in the biotech sector were SFr7.2bn in 2024, slightly lower than SFr7.3bn in 2023. Most pharma and biotech companies in Switzerland (95%) are private and in earlier stages of the development pipeline. The remaining 5%, including big pharma such as Roche and Novartis, are public. While the private fundraising market did relatively well in 2024, there were challenges in public markets, with no initial public offerings (IPOs) taking place by Swiss biotechs last year. The only capital market transaction in Switzerland in 2024 was a reverse merger transaction of Curatis. The Swiss Biotech Report 2025, authored by the Swiss Biotech Association, EY and eight other partner organisations, was launched at the Swiss Biotech Day on 5-6 May in Basel. The theme of the Swiss Biotech Report 2025, 'The Power of International Alliances', is pertinent given recent global political shifts favouring domestic operations. Last year, Swiss biotechs forged several partnerships with large pharma companies such as AC Immune and Takeda's Alzheimer's immunotherapy deal, Haya's long non-coding RNA therapy deal with Eli Lilly, and a partnership between Basilea and Innoviva to commercialise the former's antibiotic. While the Basel-Landschaft-based Idorsia also signed a deal with Viatris centred on two Phase III assets in early 2024, the former did not later pay the required development costs due to low cash reserves, and consequently, agreed to accept a reduced future milestone payment. Swiss Biotech Association CEO Michael Altorfer said: 'In an era when isolationist policies and 'me-first' approaches have gained traction, Switzerland's collaborative model offers a compelling counterproposal. None of the Swiss biotech innovators develops a new product or technology for the Swiss market alone.' The report's theme also ties in with two key Swiss sector developments. Firstly, the Swiss innovation agency Innosuisse has assumed the chair of the Eureka innovation initiative - a network of 47 countries plus the European Commission (EC) - to expand non-dilutive global research grants. Secondly, Swissmedic, Switzerland's regulatory agency, will play a role in the Access Consortium, facilitating joint approvals across Australia, Canada, Switzerland, Singapore and the UK.
